Pancreatic disease treated with pancreatoduodenectomy Surgery
Conditions
Interventions
The randomisation will be by online websolution after the results of drain amylase POD 1 are known and within the inclusion limits of the study. There are two treatment arms:
1. Early
Sponsors
Region Östergotland
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients planned for pancreatoduodenectomy with high risk for anastomosis leakage
Exclusion criteria
Exclusion criteria: Low risk for anastomosis leakage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital stay, measured at discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Overall morbidity rate classified as Clavien-Dindo =3a within 90 days 2. Mortality rate (in-hospital, 30 and 90 days) 3. Overall morbidity rate as classified by Clavien-Dindo within 90 days 4. Fistula rate according to ISGPF (grade B and C fistulas) within 90 days 5. Intraabdominal abscess rate within 90 days 6. Wound infection rate within 90 days 7. Delayed gastric emptying according to ISGPF within 90 days 8. Postpancreatectomy bleeding according to ISGPF within 90 days 9. Need of interventional radiology within 90 days 10. Need for reoperation within 90 days 11. Readmission rate within 90 days | — |
Countries
Norway, Sweden
Outcome results
None listed